Navigation Links
Safinamide Phase III Study Results Presented at 2013 MDS Meeting
Date:6/18/2013

ate. In addition, safinamide shows a very rapid onset of efficacy with significant improvements being observed in ON-time (p=0.0003) and OFF-time (p<.0001) from week two onwards. These results will be part of the regulatory submission planned to be filed in Europe and USA in QIV/2013."

"The responder rate analysis using multiple and combined criteria show compelling evidence that a substantial proportion of Parkinson's disease patients, even in advanced stage treated with safinamide obtain significant clinical benefits in all major motor symptoms thus significantly improving their quality of life", said Marco Sardina, Zambon's CSO.

SETTLE study was a six-month (24-week), randomized, double-blind, placebo-controlled international Phase III trial. It enrolled 549 patients with mid-to late-stage idiopathic Parkinson's disease (more than three years of disease duration) treated with optimized, stable doses of levodopa and standard of care (dopamine agonist, COMT inhibitor, anticholinergic and/or amantadine) for at least four weeks. Patients who were experiencing a minimum of one and a half hours of "OFF" time during the day were randomized equally to treatment with once a day safinamide (50-100mg) or placebo (standard of care including levodopa), as adjunctive treatment. Based on discussions with the regulatory authorities, the primary endpoint of the trial was the change in daily "ON" time, as assessed by the patient completed daily diary cards (18 hours/day).

Safinamide was very well tolerated. 484 patients completed the trial; the drop-out rate was similar in both treatment groups (approx. 12%). The most commonly reported adverse events were nausea, urinary tract infections, falls, back pain and dyskinesia. Transient dyskinesia occurred more frequently with safinamide, but was mainly mild, and was not associated with treatment discontinuation. Similarly, the incid
'/>"/>

SOURCE Newron Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
2. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
3. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
4. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
5. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
6. Lilly Voluntarily Terminates Phase II Study for LY2886721, a Beta Secretase Inhibitor, Being Investigated as a Treatment for Alzheimers Disease
7. NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinsons Disease and Movement Disorders
8. Epizyme Enrolls First Patient in Phase 1/2 Clinical Trial of EPZ-6438, an Inhibitor of EZH2
9. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial
10. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
11. SanBio Announces FDA Clearance for the Initiation of a Phase I/2a Clinical Trial Testing Their Cell Therapy Product, SB623, in Patients with Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 1, 2015   Royal Philips  (NYSE: PHG, AEX: ... (MR) solutions to be showcased at the International ... rd Annual Meeting & Exhibition in ... #301 will see the latest in innovations designed ... performance, enhance patient experience and provide economic value. The ...
(Date:6/1/2015)... Ill. , June 1, 2015  AbbVie (NYSE: ... Healthcare Conference on Thursday, June 4, 2015. Richard ... participate in a question and answer session at 8:30 ... of the presentation will be accessible through AbbVie,s Investor ... edition of the session will be available later that ...
(Date:6/1/2015)... 2015 Research and Markets  ( http://www.researchandmarkets.com/research/4lw2mn/global_a_dialyzer ... "Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor ... offering. The Global A Dialyzer Reprocessing ... is a professional and in-depth study on the ... industry. The report provides a basic overview ...
Breaking Medicine Technology:Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 2Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 3Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3
... , PITTSBURGH, Dec. 8 Mylan Inc. (Nasdaq: ... has entered into settlement and license agreements with Wyeth, now ... (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the ... major depressive disorder. , Pursuant to the license agreement, Mylan ...
... , ... to hospitals, reduce costs and lead to more efficient operating rooms ... once hospitals have converted to CPT, they will never convert back. ... custom packs, but have also come to realise the true cost-benefit ...
Cached Medicine Technology:Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 2Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 3Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays 4
(Date:6/1/2015)... 2015 Unlike most generator rental companies, which ... in-use periods compared to when the generator is in standby ... client uses the generator or not. WPP also offers an ... as little as a few hours — for companies that ... portable generator onsite. , “Even minor business disruptions are very ...
(Date:6/1/2015)... On May 14, 2015, the AFC/Doctors Express ... Creek Chamber of Commerce for the grand opening of ... do not offer primary care services by appointment; the ... Care staff to schedule family care procedures, such as ... p.m. the center hosted presidents, CEOs, and managers from ...
(Date:6/1/2015)... 2015 Sharenote, a leading web-base electronic ... Healthcare Industry this week in Louisiana. The entrepreneurial trio ... days to provide potential providers with the tools and ... monitor risk within their network. , Find out ... being used by more than 250 practices. , ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 There’s never a ... when it comes to non-emergency, minor illnesses. , As of ... 24/7 online access to medical care via the Internet. Patients ... smartphone, tablet or computer. , “Everyone is busy. We know ... a challenge, so we want to make it easier,” said ...
(Date:6/1/2015)... 2015 Hexagon Geospatial is pleased to ... new cloud-based subscription service that provides on-demand access to ... Both ERDAS IMAGINE and GeoMedia ... which offers a subscription model for delivering software products ... be able to quickly and easily access the right ...
Breaking Medicine News(10 mins):Health News:Worldwide Power Products Offers “Budget Billing” Contingency Generator Rental Program; Guarantees Power for Peak of Hurricane Season and Beyond 2Health News:Grand Opening For AFC/Doctors Express Cherry Creek Primary Care Clinic 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3
... Reach Statewide Olmstead,Settlement Agreement, WASHINGTON, July 2 ... in Georgia,s,eight public psychiatric hospitals and mental retardation ... communities with appropriate supports,tailored to meet their individualized ... the state of Georgia and the HHS Office ...
... the gym, take simple steps to avoid the potentially ... Before heading to the gym, you should brush up ... superbug, say doctors from Loyola University. , While infections ... and health-care settings, they are on the rise in ...
... 2 Georgia seniors enrolled,in Medicare Advantage face ... according to new data released by America,s Health,Insurance ... the impending cut to physician,payments in Medicare, many ... for the fix. Legislation currently being considered (H.R. ...
... WASHINGTON, July 2 New Hampshire seniors,enrolled in ... considered in Congress, according to new data released ... ways to halt the impending cut to physician,payments ... Advantage program to,pay for the fix. Legislation currently ...
... Pennsylvania would be one of the hardest hit ... Pennsylvania seniors,enrolled in Medicare Advantage face significant ... to new data released by,America,s Health Insurance Plans., ... impending cut to physician,payments in Medicare, many are ...
... SAN JOSE, Calif., July 2 VNUS(R) Medical,Technologies, ... of medical devices,for the minimally invasive treatment of ... patent infringement claims in the United States,District Court, ... MedTech America, Inc. (Dornier) and NewStar Lasers,Inc. d/b/a ...
Cached Medicine News:Health News:Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 2Health News:Georgia to Offer More Community Living Alternatives for Individuals With Disabilities 3Health News:MRSA Infections Can Bug Fitness Buffs 2Health News:Proposed Congressional Legislation Would Cut $143 Million from the Medicare Advantage Program in Georgia 2Health News:Proposed Congressional Legislation Would Cut $6.6 Million from the Medicare Advantage Program in New Hampshire 2Health News:Proposed Congressional Legislation Would Cut $841 Million From the Medicare Advantage Program in Pennsylvania 2Health News:VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: